Meridian Bioscience

June marks National CMV Awareness Month, a reminder that CMV is the most common infectious cause of birth defects in the United States.

Meridian Bioscience is committed to supporting healthcare providers with rapid and accurate diagnostic solutions. Alethia® provides a reliable molecular assay for congenital CMV detection, helping prevent complications and improve outcomes for newborns.

Prevent the preventable. Manage the manageable. Learn more: https://hubs.li/Q04d5VY50